| Jonathan Seale, MD | |
|
1600 Providence Dr, Waco, TX 76707-2261 | |
| (254) 313-4200 | |
| Not Available |
| Full Name | Jonathan Seale |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 1600 Providence Dr, Waco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255714739 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | BP10054659 (Texas) | Secondary |
| 207Q00000X | Family Medicine | R0124 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Home Health Of North Central Texas | Fort worth, TX | Home health agency |
| Hill Regional Hospital | Hillsboro, TX | Hospital |
| Providence Health Center | Waco, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heart Of Texas Community Health Center, Inc. | 1153370242 | 95 |
| Providence Health Alliance | 6305731068 | 129 |
News Archive
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers.
Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.
"About 80% of newly licensed nurses find their first work in hospitals," says New York University Rory Meyers College of Nursing Professor Christine T. Kovner, PhD, RN, FAAN.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
› Verified 9 days ago
| Entity Name | Providence Health Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932210838 PECOS PAC ID: 6305731068 Enrollment ID: O20040220000307 |
News Archive
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers.
Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.
"About 80% of newly licensed nurses find their first work in hospitals," says New York University Rory Meyers College of Nursing Professor Christine T. Kovner, PhD, RN, FAAN.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
› Verified 9 days ago
| Entity Name | Mclennan County Medical Education And Research Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689651440 PECOS PAC ID: 0042205155 Enrollment ID: O20040419000208 |
News Archive
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers.
Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.
"About 80% of newly licensed nurses find their first work in hospitals," says New York University Rory Meyers College of Nursing Professor Christine T. Kovner, PhD, RN, FAAN.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
› Verified 9 days ago
| Entity Name | Heart Of Texas Community Health Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568191492 PECOS PAC ID: 1153370242 Enrollment ID: O20050114000813 |
News Archive
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers.
Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.
"About 80% of newly licensed nurses find their first work in hospitals," says New York University Rory Meyers College of Nursing Professor Christine T. Kovner, PhD, RN, FAAN.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
› Verified 9 days ago
| Entity Name | Concord Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083630610 PECOS PAC ID: 0446296818 Enrollment ID: O20050707000531 |
News Archive
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers.
Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.
"About 80% of newly licensed nurses find their first work in hospitals," says New York University Rory Meyers College of Nursing Professor Christine T. Kovner, PhD, RN, FAAN.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
› Verified 9 days ago
| Entity Name | Concord Medical Group Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750790762 PECOS PAC ID: 7810117223 Enrollment ID: O20141007002567 |
News Archive
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers.
Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.
"About 80% of newly licensed nurses find their first work in hospitals," says New York University Rory Meyers College of Nursing Professor Christine T. Kovner, PhD, RN, FAAN.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
› Verified 9 days ago
| Entity Name | Hospital Care Consultants Of Hillsboro Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114449766 PECOS PAC ID: 9537431499 Enrollment ID: O20170828002027 |
News Archive
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers.
Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.
"About 80% of newly licensed nurses find their first work in hospitals," says New York University Rory Meyers College of Nursing Professor Christine T. Kovner, PhD, RN, FAAN.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Seale, MD 1600 Providence Dr, Waco, TX 76707-2261 Ph: (254) 313-4200 | Jonathan Seale, MD 1600 Providence Dr, Waco, TX 76707-2261 Ph: (254) 313-4200 |
News Archive
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers.
Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.
"About 80% of newly licensed nurses find their first work in hospitals," says New York University Rory Meyers College of Nursing Professor Christine T. Kovner, PhD, RN, FAAN.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
› Verified 9 days ago
Allison L Hulme, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-750-8200 Fax: 254-750-8326 | |
Timothy Martindale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7104 New Sanger Rd, Waco, TX 76712 Phone: 254-741-1113 Fax: 254-741-1342 | |
Dr. Brian Douglas Bull, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 North Loop 340, Waco, TX 76705 Phone: 254-202-7500 Fax: 254-202-7599 | |
Dr. Matthew R Porter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W. State Hwy 6, Waco, TX 76712 Phone: 254-313-6700 Fax: 254-313-4531 | |
Lianda Mirella Martinez, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Franklin Ave, Suite B-c, Waco, TX 76701 Phone: 254-537-6590 Fax: 254-537-6599 | |
Jacob Lutgen, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4200 | |
Dr. Aman A Shah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 |